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Abstract. In this article, the question is discussed if and how Healthcare Ethics Committees (HECs) should
be regulated. The paper consists of two parts. First, authors from eight EC member countries describe the
status quo in their respective countries, and give reasons as to the form of regulation they consider most
adequate. In the second part, the country reports are analysed. It is suggested that regulation of HECs
should be central and weak. Central regulation is argued to be apt to improve HECs accountability,
relevance and comparability. To facilitate biomedical citizenship and ethical reﬂection, regulation should
at the same time be weak rather than strict. Independence of HECs to deliberate about ethical questions,
and to give solicited and unsolicited advice, should be supported and only interfered with by way of
exception. One exception is when circumstances become temporary adversarial to ethical deliberation in
healthcare institutions. In view of European uniﬁcation, steps should be taken to develop consistent
policies for both Eastern and Western European countries.
Key words: clinical ethics, deliberation, European uniﬁcation, Healthcare Ethics Committee, legislation,
regulation, subsidiarity
Introduction
Ethics committees are important interdisciplinary
panels for the discussion of ethical questions. In
the past 30 years, two types of ethics committees
have become dominant in health care institutions:
research ethics committees (RECs),
1 which focus
on the review of medical research involving human
subjects, and healthcare ethics committees (HECs),
focussing on moral issues in patient care.
2 Remark-
ably, whereas for RECs regulatory structures have
been developed on international and national
levels, HECs have remained much less regulated.
This article analyses regulation of HECs in
Europe. The descriptive aim of the study is to
explore if and how HECs are being regulated in a
select number of European countries; its normative
aim is to discuss how HECs should be regulated.
Methods
Eight countries were chosen for this explorative
study: Belgium, Croatia, France, Lithuania, The
Netherlands, Poland, Slovakia and the United
Kingdom. The choice of countries was not
intended to be representative for Europe in its
entirety. Rather, reﬂections from a limited sample
of sufﬁciently diverse countries were to be analysed
in order to demonstrate both the variety of
concepts of clinical ethics facilities and possible
tendencies as to the regulation of HECs. The
countries can be divided into two groups: Belgium,
France, The Netherlands and the United Kingdom
have been democratic societies for a considerable
amount of time. It was assumed that deliberation
would not be entirely unknown in organisations of
public life of these countries, e.g. in hospitals and
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Poland and Slovakia are presently transitional
countries that have undergone radical changes
since the fall of Communism in 1989 and 1990.
Other than in Western countries it was to be
expected that deliberation, if practiced in health-
care organisations, would rather be in a beginning
stage.
The co-authors of this study are predominantly
clinical ethicists from the countries chosen for the
study. An exception is Poland, where no ethics
committees appeared to have been implemented
yet. However, it was decided not to exclude the
Polish contribution in order to include its thoughts
on future regulation of HECs in this country.
Initially, all co-authors were asked to contribute a
brief report about regulation of HECs in their
countries, answering the following questions:
(1) What kind of regulation of HECs (legislation or
other) exists?
(2) How should HECs ideally be regulated?
(3) What are the reasons for your preference?
Regulation is interpreted as a concern for HECs
by authorities external to the committees them-
selves, expressed in rules of diverse latitude and
bindingness. The authorities concern may relate to
both procedural and substantial questions. Proce-
dural questions include the establishment and
composition of HECs, succession of members,
operating procedures, character of products (for
example policy guidelines and procedures of moral
case deliberation) and accountability issues. Sub-
stantial questions involve the moral advice given
by the committee, most typical in the form of
moral guidelines for the institution, sometimes in
the form of conclusions of ethical case deliberation
on the ward.
As to the different types of ethics committees, the
main accent of this article lies on the level of
healthcare institutions. National committees, which
are mostly members of the European Conference of
National Ethics Committees (COMETH) (see http://
www.coe.int/T/E/Legal_Aﬀairs/Legal_co-operation/
Bioethics/COMETH/), accessed February 20, 2007),
or regional committees will be mentioned when
directly relevant for HECs and questions of HEC
regulation.
The country reports were analysed in view of
the status and reasons in favour and against
models of regulation. All co-authors have com-
mented on an earlier draft of this article, added
missing information or made suggestions as to the
discussion and conclusions.
Country reports
Belgium
Development
Since 1994, all general and psychiatric hospitals in
Belgium have been legally required to establish a
so-called ‘local ethics committee for tasks related
to both RECs and HECs. The combination of
research and clinical ethics in one single committee
can be explained by the genesis of ethics commit-
tees in Belgium (Meulenbergs et al., 2005). In the
remainder of this study, this type of committees
will be called ‘mixed committee(s). From as early
as 1984, the Order of Physicians issued guidelines
establishing research ethics committees. In 1992 the
Order of Physicians National Council broadened
these committees scope by appending systematic
reﬂection on the ethical and philosophical aspects
of healthcare practice to the range of committee
tasks.
Regulation
Due to a ruling by the Belgian Court of Arbitration
in 2000, the HEC-related tasks do not include
ethics consultation any longer. The court decided
that the Belgian federal lawmaker was unauthor-
ised to set ethics consultation as a committee task
since the competence to legislate on person-related
issues in healthcare resides with the regional
authorities.
In May 2004, the functioning of ethics commit-
tees changed owing to the new law on human
experimentation that introduced the provisions
of the EU Clinical Trials Directive 2001/20/EC
(European Parliament, 2001). The already existing
predominance of protocol review (Englert et al.,
2001) over health care ethics tasks was reinforced,
especially by setting competing time frames within
which ethics committees have to review protocols
(Trouet, 2004). The new law also introduced a
funding system for ethics committees with regard
to research ethics. Committees with a principal
focus on healthcare ethics are not eligible for
funding any more.
Apart from the speciﬁc tasks, the Royal Decree
of 12 August 1994 also governs a committees
composition as well as its functioning. The current
legal situation can be held inadequate. Allocating
both REC and HEC related tasks to one single
committee ignores the fundamental differences
between research ethics and healthcare ethics,
e.g. with regard to required expertise (Riis, 1998).
Notwithstanding the legal framework, some
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established separate RECs and HECs (Vermylen
and Schotsmans, 2000).
Future perspective
Today Belgian HECs are already regulated on a
national scale. Due to this, every hospital has an
ethics committee performing a multiplicity of com-
mittee tasks. In the past, this national character of
HEC legislation has been shown to function as an
important impetus to establish local ethics struc-
tures. Hence, the proposed integrative view on
ethics committees should also be applied through
national legislation. This bears not only the advan-
tage that HECs have similar structures but also that
quality management and concerted action among
HECs can be effectively dealt with.
Croatia
Development
Since 1997, the Croatian Law on Health Protection
has required the establishment/founding of ethics
committees (Law on the health protection, 1997).
A 2003 revision (Law on the health protection,
2003) left the legal requirements for the establish-
ment of ethics committees unchanged. Each health-
care institution in Croatia is required to have an
ethics committee consisting of ﬁve members (three
medical, two non-medical). In 2001, the National
Bioethics Committee for Medicine of the Croatian
Government was founded (Directive on the estab-
lishment of the National Bioethics Committee for
Medicine, 2001). This independent and multidisci-
plinary advisory body is involved in policymaking,
education, and debates on ethical issues on a
national level. Furthermore there are ethics com-
mittees at four medical faculties: at the Faculty of
Veterinary Medicine and at the Faculty of Phar-
macy and Biochemistry in Zagreb, at the Institute
for Anthropology, the Institute for Medical
Research, the Institute Rudjer Bosˇkovic as well as
other research institutions. All these committees
basically deal with research.
Regulation
Croatia has decided for a top down approach for
the implementation of ethics committees in health-
care institutions. These are ‘‘mixed’’ committees, a
type of ethics committee which combines the tasks
of both HECs and RECs. There are several
problems with this type of regulation. First and
foremost it does not relate to the committees in
research institutions. Moreover, by the Law on
Health Protection Pharmacies, homecare institu-
tions and primary healthcare facilities are consid-
ered to be healthcare institutions as well. Having
only 2–6 employees on average, separate ethics
committees appear to be not feasible for these
institutions.
The 2003 Law on Drugs and Medical Devices
(Law on drugs and medical devices, 2003) has now
centralised the review of research protocols at one
specially established ethics committee on a national
level. Following the Law on Health Protection,
ethics committees in healthcare institutions are also
required to review research protocols. This obvi-
ously creates confusion. Furthermore, research in
hospital settings has shown that most ethics
committees considered the analysis of research
protocols as their main function, while the other
tasks were neglected.
Further perspective
Both the Law on Health Protection and the Law
on Drugs and Medical Devices will be revised. To
improve regulation of ethics committees, research
ethics and clinical ethics should be distributed to
HECs and RECs respectively. Ethics committees in
healthcare institutions should be transformed into
HECs by changing the legal provisions. Additional
efforts should be put in the members education.
Furthermore, HECs should be required in hospital
settings, whereas for the other types of healthcare
institutions moral problems could be directed to
local or regional HECs.
France
Development
Healthcare ethics at a local level was not men-
tioned in French law until 2002, though many
hospital-based ethical structures had been created.
In 2002 and 2004, two legal steps concerning
clinical ethics were taken. However, none of these
relates to the ‘committee model. In 2002, the
following sentence was inserted with no further
speciﬁcation: ‘‘They [hospitals] perform, within
their structure, a reﬂection on ethical issues related
to the patients reception and medical care’’
(Art. L611 CSP, of the Law No. 2002-303, 2002).
Strictly speaking, performing reﬂection does not
mean setting up an ethics committee.
In August 2004, another insertion was placed
following two ofﬁcial reports (a document about
ethics and healthcare in France requested by the
Ministry of Health, and an opinion of the latter by
the National Ethics Committee (Cordier, 2003,
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re´ﬂexion e´thique] are created at the regional or
interregional levels; they work in connection with
university hospitals, and they are sites of education,
documentation, interdisciplinary meetings and
discussions on ethical issues in the ﬁeld of health.
They are also regional and interregional observato-
ries with regard to healthcare practices. They par-
ticipate in the organisation of public debate so as to
foster information and consultation of citizens on
bioethics issues’’ (Art. L1412-6 CSP, added by law
2004-800regardingbioethics,2004).AsofFebruary
2007, however, Espaces E ´thiques have still not been
oﬃciallycreated.Aworkinggrouphasbeensetupat
the Ministry to prepare speciﬁcatory decrees, allow-
ing this law to become eﬀective.
Regulation
The 2002 law is not a strict regulation. Neither has
it led to any form of evaluation. Rather, hospitals
are being encouraged to support various forms of
healthcare ethics. Many of them already have an
internal structure dedicated to clinical ethics.
Probably about half of them sometimes perform
ethics consultation and advisory work (Guerrier
et al., 2004). The 2004 law directly refers to the
Espace E ´thique of Assistance Publique Ho ˆpitaux de
Paris, founded by Emmanuel Hirsch in 1995. For
the ﬁrst time, ‘‘oﬃcially recognised’’ bodies in
healthcare ethics are about to be implemented in
France. These bodies are not to be involved in
decision-making on the ward. Rather, they support
education and reﬂection. Since many and very
diverse structures already exist, some operating at
a regional level, their development and potential
transformation is a possible source of diﬃculty.
Further perspective
The very ﬁrst issue to be addressed in order to
build up Espaces E ´thiques is to identify, describe
and foster existing initiatives. Many HECs could
become part of Espaces E ´thiques network activi-
ties. As for the advisory work in this realm, no
further regulation should be introduced at the
moment because of two reasons. First, their prior
goal is education and personal commitment in
ethical reﬂection; second, a much better under-
standing of requests of such advisory procedures
should be acquired prior to any regulation.
Lithuania
Development
The establishment of HECs (called ‘medical ethics
commissions) is based on two legal documents.
First, the Health Care System Law of the Republic
of Lithuania, passed by the Parliament in the early
90s, requires the establishment of HECs in the
largest health care institutions (HCI). The same
law has envisaged the founding of the Lithuanian
National Bioethics Committee, which is responsi-
ble for co-ordinating and supporting HECs.
Second, the ‘Model Guidelines for Medical
Ethics Commissions, issued by the Ministry of
Health in 1997, deﬁne the mission, functions,
establishment and composition of HECs. These
guidelines award an ethics committee with far-
reaching competencies. For example, a HEC is
required to monitor health care providers compli-
ance with principles of medical ethics. Further-
more, it may facilitate a HCIs decision-making in
controversial ethical cases and in conﬂicts between
health care professionals and patients.
Regulation
As to the establishment and composition, members
of a HEC are being elected by secret vote during a
general meeting of the employees of the HCI for a
3-year period. A committee regularly consists of
7–15 members, the exact number being decided
upon by the general meeting. The appointment of a
chairperson, deputy chair and secretary are left to
the HECs self-regulation. These persons are elected
by a simple majority vote at the committees
constituent meeting. Subsequently, each HEC
may develop its own Guidelines in accordance to
the Model Guidelines of the Ministry of Health. A
HEC should receive technical support from the
HCIs administration.
Future perspective
An anonymous evaluative study at the beginning
of 2000 (Gefenas, 2001) showed that, instead of
deliberating about medical ethical problems, most
HECs had taken over the role of a sentinel. This
means that HECs were limiting themselves to
resolving diﬃcult situations related to the health
care professional – patient relationship as well as
conﬂicts amongst health care professionals them-
selves, e.g. the refusal to participate in rounds with
the chief of department, cases of caregivers being
crude to patients and the like.
The most important issue related to the func-
tioning of HECs in Lithuania is not to develop a
certain type of regulation (e.g. national versus
smaller scale), but to clarify the way medical ethics
is conceptualised in and by HECs. Assigning ethics
committees the role of a ‘‘moral police’’, and using
them for disciplinary sanctions as well as a
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implies an authoritarian, non-deliberative concept
of medical ethics. Attempts to ‘‘implement’’ such
an interpretation of medical ethics by using HECs
obviously give counterproductive results. Most
likely the idea of committees as facilitators of
ethical deliberation will be spoilt.
The strategy to issue Model Guidelines for
HECs at the national level, however, can be
considered an adequate step. The procedure to
introduce these guidelines at each HCI leaves room
for interpretation. Each HCI could modify those
guidelines in a speciﬁc way, according to the local
institutional needs. One of the most important
missing elements has been the lack of a clear and
realistic implementation strategy. Such a strategy
should provide adequate ﬁnancial resources (not
only a ‘‘technical assistance’’) to establish a HECs
secretariat trained in health care ethics, and capa-
ble to sustain continuity of the committees activ-
ities.
The Netherlands
Development
In The Netherlands, legal regulation solely exists
for research ethics committees (REC). The 1999
Medical Research Involving Human Subjects Act
(WMO) requires all scientiﬁc medical research
involving human subjects to be reviewed by an
oﬃcially recognised REC (Ministerie van Volks-
gezondheid, Welzijn en Sport, 2000). Recognition
of RECs is granted by the Central Committee
Medical Research Involving Human Subjects
(CCMO). The CCMO is a national ethics commit-
tee exclusively dedicated to research ethics. Next to
being entitled by law to guarantee recognition to
local RECs, it is a committee of appeal.
HECs in The Netherlands date back to the
beginning of the 1970s. During the ﬁrst two
decades, most of them were ‘mixed committees.
Next to the review of research protocols, their
responsibilities included the development of guide-
lines about moral questions in healthcare organi-
sations (e.g. the hospital, the nursing home etc.),
educative programmes for members, healthcare
providers, patients and the public, and ﬁnally
moral deliberation on the ward (van der Kloot
Meijburg, 1990). Regulative as well as pragmatic
reasons led to the diﬀerentiation of ethics commit-
tees into RECs and HECs. Pragmatically, research
ethics tended to marginalise clinical ethics when
both tasks belonged to the same committee. In this
case, protocol review can turn out to be so time
consuming as to become a committees dominant
or even its only activity. This development was
intensiﬁed by regulation. The more administrative
authority was granted to RECs, the more clinical
ethics was neglected.
Regulation
HECs have been and continue to be a bottom-up
enterprise. Next to the mixed committees, a num-
ber of committees were founded as separate HECs
from the beginning. Without central regulation,
statutes for HECs uniformly deﬁne the tasks of
these committees according to the international
consensus about what HECs are supposed to be
doing. Locally, however, committees have accen-
tuated their tasks differently, both according to
agreements with the board of directors of the
institution, and according to the consideration of
requirements by hospital wards.
Future perspective
During recent years, the connection of HECs to
patient care has become an issue (Ten Have, 2001).
In 1999, the Dutch Association of Bioethicists
(NVB) recommended to improve the connection of
HECs to daily practice by maintaining the concept
of ethics committees (Brom et al., 1999). A year
earlier, the Centre for Ethical and Philosophical
Aspects of Care (CELAZ) suggested transforming
HECs into steering groups to improve integration
of moral deliberation into the management, quality
assurance programmes, and healthcare delivery
on the wards (College voor Ethische en Lev-
ensbeschouwelijke Aspecten van de Zorgverlening,
1998).
Discussion papers like these are not yet regula-
tion. Their ﬁrst aim is to indicate problems and to
inspire discussion. As a next step, a ‘platform on
moral deliberation was set up at the Ministry of
Health in 2004, in order to inventory concepts of
moral deliberation on the ward. As of February
2007, discussions about implementation of health-
care ethics committees have been on the way within
the working group of the Ministry of Health. As
far as regulation is concerned, no distancing from
the principle of self-regulation has been observed
so far.
Poland
Development
HECs do not yet exist in Polish hospitals. Neither
is there legal nor ethical regulation concerning
HECs.
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The only ethics committees in Poland which could
play, at least to some extent, a role similar to
HECs, are medical ethical committees of medical
councils or chambers of physicians and dentists.
These committees operate at the national and
regional level, and deal with issues of medical
ethics (deontology). Their inﬂuence on health care
policy and clinical decision-making is however very
limited.
The Medical Ethics Committee of the Supreme
Medical Council of the Polish Chamber of Physi-
cians and Dentists (PCHPD) was set up in 1990,
following a recommendation of the ﬁrst General
Medical Assembly, which is the highest authority
of the PCHPD. The committee drafted the Code of
Medical Ethics, which was ﬁnally adopted by the
second General Medical Assembly in 1991. This
code contains ethical norms that should be fol-
lowed by all Polish physicians and dentists. Beyond
this, the code has indirect legal signiﬁcance.
Medical councils of regional chambers of
physicians and dentists have set up their own
Medical Ethics Committees. The role of regional
committees is to monitor and give opinions on
professional conduct of local physicians, to inform
the Screeners for Professional Liability about norm
violations, to propose solutions to conﬂicts, to take
part in public discussions on bioethical issues, to
deliver opinions on draft legislation concerning the
protection of health and practicing as a physician,
to table motions for legislative initiative and to
promote bioethical education among young med-
ical doctors.
All Medical Ethics Committees are monodisci-
plinary bodies, composed only of medical doctors.
They gather 6–12 times a year. Each of the Medical
Ethics Committees has its own statute, which
governs in detail its functioning and internal
organisation. The statutes differ signiﬁcantly from
each other in respect of particular regulations
concerning organisational and functional issues.
Future perspective
Future HECs in Poland should be regulated and
standardised on a national level in order to assure
their accountability. Regulation, therefore, should
address the following topics: (1) the tasks of HECs;
(2) the size and composition of the committees; (3)
membership requirements; (4) rules of appointing,
ﬁnancing and functioning of the committees; (5)
case consultation procedures; (6) the storage of
documentation of consults; and (7) review of
committee processes and recommendations. These
basic organisational and functional matters should
be regulated by law, because the activities of the
committees bear directly on patients rights, enable
and guide life-and-death decision-making, and
provide ethical input into hospital policies and
guidelines. HECs also play a signiﬁcant role in the
dialogue about medical futility and rationing of
scarce medical resources. Legal acts and decrees
should, however, leave room for HECs self-regu-
lation. Internal statutes of the committees should
be consistent, not only with the law on HECs, but
also with the norms of medical ethics as expressed
in various national as well as international codes
and recommendations.
Slovakia
Development
The ‘‘Velvet Revolution’’ of November 1989
marked a new start for the development of
bioethics in the Slovak Republic. Since the very
beginning, the idea of ethics committees in general
has been supported by the Ministry of Health
(MH). In the autumn of 1990, the Central Ethics
Committee (CEC) was founded at the MH. At the
same time, in the reform atmosphere following the
‘‘Velvet Revolution’’, several informal working
groups on medical ethical issues were formed at
the Faculties of Medicine, as well as in the teaching
hospitals, research institutes, and also within sev-
eral member societies of the Slovak Medical
Association, and the Slovak Medical Chamber.
Later on, these groups were transformed into
mixed committees. The ‘‘know-how’’ support for
these review and ethics advisory bodies was pro-
vided mostly by the CEC: by means of consulta-
tions, informal recommendations and professional
guidance. No reporting or hierarchical relation-
ships were introduced. In June 1992, the
‘‘Guidelines on Establishment and Work of Ethics
Committees in Health Care Facilities and Biomed-
ical Research Institutions’’ (Guidelines) were elab-
orated by the CEC, and published in the form of
the MHs recommendations. The Guidelines
required and gave a speciﬁc guidance on the
establishment and work of local ethics committees.
The new health law was adopted in 1994.
Together with subsequent legislation, it helped to
create a new legal milieu for medicine and health
care. The ‘‘reform health legislation’’, approved in
September 2004 by the Slovakian parliament,
brought in more profound changes, however. It
consisted of 7 new laws. The most important
for ethics committees issues were the Law
No. 576/2004 Coll. on health care and the Law
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as later amended.
Regulation
The Law No. 576/2004 Coll., which became
effective on January 1, 2005, requires all inpatient
health care facilities in the Slovak Republic to have
ethics committees established to deal with ethical
problems connected with health care provision
(and to review and monitor ethical aspects of ‘in
house conducted biomedical research, including
drug clinical trials). It also asks the regional health
authorities to establish ‘‘regional’’ ethics commit-
tees for the same purpose, i.e. to oversee and deal
with ethical problems of health care, public health
and biomedical research at the territory of their
respective regions. Regulation of the MH on ethics
committees is under preparation (to be issued
under the new law). It is supposed that it will
require the registration of ethics committees, and
thereby also their fulﬁlling of certain criteria (e.g.
detailed requirements concerning statutes, mem-
bership, education and training of committee
members, etc.).
The approximate number of ethics committees
in the whole country is between 40 and 50,
established mostly at major hospitals and at the
medical research institutes that provide also highly
specialised inpatient care. Ethics committees occa-
sionally (so far quite rarely) take on the consulta-
tion of ethically difﬁcult cases, or, even more
seldom, review and provide advice on local/
regional health policies. The same applies with
regard to (‘‘regional’’) ethics committees estab-
lished by the regional health authorities in the eight
regions of the Slovak Republic. These ECs are
supposed to review and give advice on ethical
issues connected with outpatient care and biomed-
ical research.
The Central Ethics Committee has been much
involved in the preparatory work on the pending
regulation. It has also been very supportive in the
development or re-activation of ethics committees
throughout the country. Ethics support in clinical
practice is felt to be a necessary pre-requisite for
the development and reform of Slovakias health
care system, which is still struggling with the
consequences of the profound transformation
undertaken during recent years.
Future perspective
HECs (or similar bodies) should be clearly regu-
lated by law. On top of this, there should be more
detailed precepts on practicalities of their estab-
lishment and operation – these could be at a
ministerial decree level issued under speciﬁc legis-
lations provision, or at the level of guidelines
issued by the MH or a similar state authority.
There should be a system of HECs, deﬁned in
the law, so their responsibility and competencies
are clearly deﬁned and visible both for the health
care professionals and for the general public.
Misuses of HECs ‘‘power’’ should be considered
in advance (considering the particular national
‘cultural aspects) – and prevented as much as
possible. The important cultural and religious
realities should be borne in mind and thoroughly
and wisely considered and dealt with.
Furthermore, there should be a system of
education (basic – introductory, and continuous)
for members of HECs, required by law, or by a
ministerial regulation (e.g. at/within registration or
accreditation awarding and its renewal). Reasons
for this are basically the growing interest and need
for clinical ethical support (Glasa, 1993, 1995,
2000a, b, 2004; Glasa et al., 1996, 1999, 2000;
Slovak Ministry of Health, 1994).
United Kingdom
Development and present situation
Clinical ethics committees (CECs) are a recent
development in the UK. A survey of all National
Health Service Trusts carried out in 2000 found
that of the 400 Trusts then in existence only 20 had
a CEC (Slowther et al., 2001). This number has
increased to 78 in 2005 (Slowther et al., 2004). The
development of CECs in the UK has been a
bottom up rather than a top down process, with
the impetus for establishing a committee arising
from the experience of health care professionals
facing ethical diﬃculties in their daily practice.
Thus, unlike research ethics committees, which are
closely regulated in the UK, there is no formal
regulation of clinical ethics committees in either the
public or private health care sector.
Regulation
Ethics support for health care professionals in the
UK is obtained from a variety of bodies including
CECs, professional organisation ethics commit-
tees, the ethics section of the British Medical
Association and regulatory bodies such as the
Human Fertilisation and Embryology Authority.
However, there is no overarching regulatory
framework for ethics support in health care, and
in particular there is no requirement for health care
institutions such as hospitals to have a formal
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arise in clinical practice. Standard setting and
regulation of health care institutions is the respon-
sibility of the Health Care Commission. Standards
include speciﬁc requirements relating to broad
ethical principles, for example that organisations
have systems in place so that patients and their
relatives are treated with dignity and respect
(Department of Health, 2004), but the mechanism
for meeting these requirements is not articulated.
The royal College of Physicians in the UK
recently established a working party to look at
ethics support and clinical ethics committees in the
UK. Its report, ‘Ethics in practice: Background
and recommendations for enhanced support
(Royal College of Physicians, 2005), was generally
supportive of the development of clinical ethics in
the UK and recommended that: ‘Health care
institutions should review their existing arrange-
ments for providing advice and education, and
implementing guidelines on the recognition and
handling of ethical uncertainties and dilemmas in
clinical practice.
The Report also made speciﬁc recommenda-
tions regarding CECs including the need for an
agreed statement of core competencies for an
effective CEC, and the provision of education
and training for members to meet them. The UK
Clinical Ethics Network, a national network of
CECs, has established a sub-committee to look at
developing a set of core competencies, and recom-
mendations for training of CEC members. The
Network is an independent organisation and has
no regulatory authority. However, it is to be hoped
that the recommendations of the RCP Report and
the work of the Network will encourage the
Department of Health to consider a more explicit
requirement for health care institutions to have a
mechanism for addressing ethical issues arising in
clinical practice.
Future perspective
In the UK context, where there is a nationally
regulated, publicly funded health service, regula-
tion of clinical ethics committees would best sit
within the overall regulatory and monitoring
framework of health care provision rather than
within a legislative framework. A legal requirement
for health care institutions to have a clinical ethics
committee would still necessitate the establishment
of a regulatory and monitoring structure to ensure
that the law has a meaningful impact on patient
care.
A separate regulatory framework for CECs,
such as the existing framework for research ethics
committees in the UK, would set clinical ethics
support apart from the day-to-day provision of
patient care. Inclusion of clinical ethics support in
the regulatory standards and monitoring processes
that govern delivery of health care (overseen by the
Health Care Commission in the UK) would
emphasise the integral role of ethics in all clinical
and organisational decision-making. Within the
general regulatory framework, speciﬁc criteria
could then be set regarding clinical ethics commit-
tees to address competency, training and evalua-
tion of the support provided.
Discussion
Regulation of HECs: descriptive aspects
Historic background
Seven of the eight countries in this study had
installed HECs in at least a few healthcare insti-
tutions by February 2007. At the beginning, most
ethics committees were mixed committees, fulﬁlling
both HEC- and REC-related tasks (Lebeer and
Moulin, 2000, 2001). In some countries, review of
research protocols became their prevailing activity,
and HECs were founded separately to deal
with issues of clinical ethics. With regard to the
purpose of HECs there have been diﬀerences
between Western and Eastern European countries.
In Eastern Europe, conﬂict resolution, manage-
ment of moral crisis, and assistance in moral
quandaries have prevailed. In Western Europe,
HECs have rather been conceived of as facilitators
of ethical reﬂection. Beylevelds and others critique
of the temporary use of HECs for the sake of
crisis management in the UK (Beyleveld et al.,
2002) can be interpreted as an indication that this
has been perceived as a deviation from an accepted
standard.
In the transitional countries of Central and
Eastern Europe, ethics committees were set up
during and after fundamental societal and political
changes. After the fall of communism in 1989 and
1990, health care systems of former totalitarian
states had to be transformed and assimilated to the
emerging democratic societies. Founding HECs
under these circumstances has rather been a top
down process, as the example of Croatia shows.
Moreover, regulation of these committees has been
both central and strict. Laws were authorised on a
national level, and complemented by ministerial
NORBERT STEINKAMP ET AL. 468decrees and guidelines of national ethics commit-
tees.
In Western Europe, the development has been
almost reverse. Numerous HECs were rather local
initiatives at the beginning, answering to a per-
ceived need to discuss moral problems in patient
care. In this bottom up approach, regulation has
mostly remained weak and decentralised. It seems
that in these countries, it is feared that too much
regulation might diminish the HECs contribution
to the development of biomedical citizenship and
democratic structures in healthcare (see Lebeer,
2003). However, the lack of a well-regulated super
regional structure could as well be seen as a
disadvantage if compared to RECs.
Types of regulation
To analyse regulation of HECs, the following two
dichotomies will be distinguished: central or local
regulation, and strict or weak regulation. Central
regulation refers to the national and supranational
(e.g. European) levels, whereas ‘local regulation
implies anything below. In central regulation,
authority can rest either with the legislator, a
government agency (e.g. a ministry), a national
bioethics commission or European res. global
organisations. Local regulation, instead, emanates
from local administrative bodies, health care trusts
or health care institutions.
Under a strict type of regulation, compliance of
ethics committees with pre-deﬁned moral and
procedural standards and rules may be required.
HECs may as well be equipped with the authority
to require obedience of healthcare providers to
their guidelines. Weak regulation, instead, leaves
more room to the committees for independent
reﬂection. It refrains from interfering with the
committees autonomy. Put positively, the core of
weak regulation is to facilitate or contribute to
moral deliberation within HECs and health care
organisations.
Our hypothesis is that strict and weak types of
regulation correspond with diverging ideas about
the purpose of HECs and with different underlying
concepts of medical ethics. Ascribing ethics com-
mittees the authority to solve conﬂicts and to
supervise morality may require a more rigorous
way of control of the committees themselves as
well as their addressees (strict regulation). If the
ethics committee is predominantly conceived of as
a facilitator of reﬂection, more latitude may be
appropriate (weak regulation). Considering these
distinctions, the following overview of types of
regulation can be given (Figure 1).
Regulation of HECs in Croatia, Lithuania and
Slovakia has a tendency to be strict and central at
the same time. Belgium and France have imple-
mented central regulation as well. In terms of
bindingness, however, it appears to be weaker and
more facilitating than in the Eastern European
countries. Committees in the Netherlands and the
United Kingdom are almost self-regulated.
In Croatia, Lithuania and Slovakia, national
ethics committees in combination with legal norms
and provisions regulate the installation and a
number of procedural aspects concerning HECs.
In Lithuania, HECs were conceived following the
idea of deliberative bodies when they were set up.
However, in reality, these committees have been
criticised for having become sentinels. According
to evaluative research, these tensions can be traced
back to different ideas about medical ethics held by
healthcare institutions, committees and medical
ethicists (see the country report from Lithuania,
and Gefenas, 2001).
In Western Europe, the purpose of HECs is
somewhat more clearly the facilitation of moral
deliberation rather than managing conﬂicts or
supervising a substantial moral position. Accord-
ingly, latitude as to the organisational forms of
clinical ethics is broader even in those countries in
which HECs are regulated by national laws.
National legislation in France refers to clinical
ethics in general, not to ethics committees specif-
ically, and does not mention ethics consultation.
However, as HECs have already been installed in a
number of French hospitals, the respective legal
norms can be interpreted so as to connect the
committees to local ethics networks, and to link
these networks to a regional ethics centre (Espace
E ´thique). The French National Consultative Bio-
ethics Committee has supported the aim of these
legal prescripts (CCNE, 2004).
Belgian legislation has required local ethics
committees for hospitals since 1994. Originally,
no difference had been made between RECs and
Central regulation 
Lithuania   
Croatia    
Slovakia 
Strict regulation         
The Netherlands 
United Kingdom 
Local regulation 
Belgium 
France 
Weak regulation 
Figure 1. Types of regulation.
REGULATION HEALTHCARE ETHICS COMMITTEES 469HECs. In fact, the regulation of clinical ethics has
primarily been left to the local administration of
hospitals. The Belgian country report demonstrates
the importance of a careful separation between
HECs and RECs. At the same time, it shows the
signiﬁcance of balance between the two types of
committees as far as regulation is concerned.
In the Netherlands and the UK, the develop-
ment of HECs has been a bottom up process. As a
consequence, regulation of HECs still widely rests
with healthcare institutions, (umbrella) organisa-
tions of hospitals or (in the UK) healthcare trusts.
In both countries a close connection between
HECs and daily healthcare provision is aimed at.
Similar to the Dutch Association of Bioethicists
(NVB) and the Centre for Ethical and Philosophical
Aspects of Care, the UK Clinical Ethics Network
and the Royal College of Physicians have recently
set up working groups to explore ways to improve
the contribution of clinical ethics support services
to moral deliberation on the ward (Royal College
of Physicians, 2005).
Regulation of HECs: normative aspects
The normative question as to how HECs should be
regulated will be discussed in three steps. First,
arguments in favour and against central and local,
strict and weak regulation are analysed. Second, it
will be explored whether the weight of these
arguments changes when speciﬁc circumstances in
particular countries are taken into consideration.
Third, suggestions will be made as to the regulation
of HECs in Europe. In anticipation of further
European uniﬁcation it will be considered what
type of regulation would be preferable, and what
should be regulated to let HECs develop to live up
to their proposed purposes.
Central or local regulation
In the light of the country reports it is assumed that
the following four factors can be inﬂuenced by the
scope of regulation: (1) the relevance and appreci-
ation of HECs; (2) mutual comparability and
consistency of the work of HECs; (3) avoidance
of redundancy by co-ordination of the committees
work on guidelines and ethical case deliberation;
(4) connection and adjustment of HECs to daily
healthcare practice. The question is if these factors
are better served by central or by local regulation
and, if there are differences, for which one of them
central regulation is to be preferred and for which
one local regulation would ﬁt better.
The formal authority of HECs to enface their
addressees compliance to guidelines and judge-
ments is limited compared to the authority of
RECs. Therefore, it is essential for HECs to be
relevant and appreciated as advisory bodies.
According to the Belgian contribution, the rele-
vance of HECs can be increased and maintained by
distinguishing clearly between research ethics and
clinical ethics. Furthermore, the development of
education programmes for committee members as
well as a good structural integration of HECs into
the procedures of healthcare institutions are
expected to improve the committees relevance for
institutional healthcare delivery. The better their
quality, the more relevant they can be.
It can be assumed that central regulation can
improve and strengthen a committees relevance on
a higher organisational level. It should not be
concluded, however, that central regulation is the
only way to achieve this goal. Rather, it can be a
supportive means, granting both non-regulatory
co-ordination and local regulatory instruments a
more signiﬁcant impact.
Second, regulation may improve the compara-
bility of different committees, and the consistency
of their advisory work within a larger context, for
example a region or a country. As to the proce-
dures, composition, requirements for membership,
methods of fulﬁlling basic tasks as well as evalu-
ation of the committees work, comparability can
for instance be improved by shared standards. In a
similar way, the development of guidelines about
substantial moral questions could be co-ordinated.
Third, the pragmatic consideration that net-
working capability of HECs is improved can be
another argument in favour of central regulation.
With a well-developed structure of central regula-
tion of HECs, the already existing hospital policies
could not only be co-ordinated in a better way, but
also used as a source for policy development in
other hospitals, by national ethics commissions or
by the legislator. As with the other two factors,
regulation on the central level is a complement, and
could be implemented following considerations of
subsidiarity: if either local regulation or non-
regulatory structures appear to be insufﬁcient,
additional support can be given effectively by a
central regulatory authority.
According to the principle of subsidiarity, over-
centralisation should be avoided. For HECs, as a
consequence of over-centralisation, space for
reﬂection and the connection to daily work would
easily be jeopardised. An advantage of local
regulation, therefore, lies in the fourth factor,
NORBERT STEINKAMP ET AL. 470namely that it can better adjust and connect HECs
to daily healthcare delivery. The British country
report points out that the location of regulation in
nationwide structures may enlarge the distance
between HECs and healthcare delivery. Such a
development might be avoided by linking HEC
regulation to an intermediate level, e.g. to networks
of hospital sponsors or healthcare trusts.
In summary, regulation can be a reasonable
means to increase the quality and status of HECs if
carefully applied. Central regulation can improve
the relevance and appreciation of HECs, and
broaden their comparability and consistency on a
larger scale. Furthermore, there are pragmatic
advantages, for example a better networking capac-
ity. Avoidance of alienation from daily healthcare
delivery, particularly from the institution where the
HEC is located, would render small-scale regula-
tion preferable instead. Central regulation in
connection with local networks seem to be a
stronger alternative than either to limit regulation
to the local sphere or to leave all the co-ordination
to non-regulatory networks. A good connection to
daily healthcare delivery remains an important task
under all circumstances, and can be guaranteed by
other means, for example by a structured interac-
tion between the committee and moral deliberation
on the ward (Steinkamp and Gordijn, 2001).
Strict or weak regulation
The question if regulation of HECs should rather
be strict or weak is related to the question of the
committees accountability. Strict regulation sub-
jects HECs to rules with a strong binding force.
Furthermore, it entitles the committees to control
and monitor their addressees. Weak regulation of
HECs, instead, can be interpreted both in a
negative and in a positive sense. Negatively it
means less interference with the autonomy of the
committees and their target groups; positively it
means the facilitation of independent reﬂection.
To what extent a HEC can be held accountable
for its advice depends on the purpose, tasks and
responsibilities ascribed to it (Ashcroft, 2005;
Reeves and Brody, 1992). Comparing the countries
participating in this study, three ideas in terms of
the purpose of HECs can be identiﬁed. According
to the ﬁrst idea, a HEC is an interdisciplinary panel
to facilitate and practise moral deliberation and
reﬂection in institutional healthcare delivery.
According to the second idea, the committees
purpose is to directly intervene and give advice in
medical decision-making. Following the third idea,
a HEC is conceived of as a group of moral experts
supervising the adherence of healthcare providers
and institutions to a ﬁxed set of moral norms.
As far as the orientation towards a projected
purpose of HECs is concerned, a preference in
clinical ethics can be identiﬁed in favour of the ﬁrst
idea,namelythatHECsshouldbepanelstopractice
and facilitate reﬂection (Wilson Ross et al., 1993;
van der Kloot-Meijburg and Ter Meulen, 2001).
Next to granting space for these activities, a facil-
itative HEC would aim to support and facilitate the
responsibility of healthcare providers as well.
Furthermore, a facilitative HEC would best ﬁt the
general goal of biomedical citizenship and demo-
cratisation in the health care sector, which has been
deﬁned by Lebeer as a leading idea of clinical ethics
in Europe (Lebeer, 2003). A HEC conceived of as a
surveillance panel, instead, would rather limit the
autonomy of its target groups than be supportive in
guiding reﬂection about moral questions in health-
care delivery (Gefenas, 2001).
Remarkably, in Western European countries
ideas about purpose, tasks and responsibilities of
HECs have ﬁrst emerged without there being any
regulation at all. In Eastern European countries,
instead, a relatively strict form of regulation has
been in place from the beginning. In view of these
differences, a well-considered middle position,
pointed out in the recent UNESCO Guide No. 2,
‘Bioethics Committees at Work (UNESO, 2005),
might be suggested as an orientation mark. The
report argues that freedom and independence yield
accountability in the ﬁrst place. To ensure account-
ability on a long-term basis, however, a certain
degree of regulation is necessary. If the rules and
regulations become too strict, and if they grant
insuﬃcient latitude, accountability can in turn be
undermined. Applied to the situation of HECs, it
can be concluded that regulation should be as strict
as necessary to ensure accountability, and as weak
as possible to refrain from undermining it.
As to the speciﬁc forms of regulatory instru-
ments to safeguard accountability, Fry-Revere has
suggested to consider ﬁve levels: professional self-
regulation, licensure and professional discipline,
government contracting, judicial remedies, and
government commissions (Fry-Revere, 1992). For
the development of such speciﬁc forms in the
context of the European Union, further research
would be recommendable.
Do the arguments shift depending on country speciﬁc
conditions?
The general pre-supposition has been that the
main purpose of HECs lies in facilitating ethical
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purpose of regulation is to support HECs to live
up to this standard, central and weak regulation
appears to be preferable. The question rises,
however, whether or not the validity of this
conclusion is context-independent. The more spe-
ciﬁc question may be asked if HECs in transitional
countries should be regulated in the same way as in
established democratic societies. Are there relevant
differences, which justify or necessitate variations
of the concept of regulation?
Two differences will brieﬂy be considered. First,
due to social and political conditions in the
healthcare institutions of a particular country,
HECs may temporarily be assigned a purpose
other than (the facilitation of) ethical reﬂection.
Second, during the implementation of a HEC,
preliminary arrangements may have to be made so
as to enable the committee to gradually grow into
the role deﬁned for it.
As to the ﬁrst point, the purpose of ethical
reﬂection generally applies to HECs under all
societal circumstances, in established democracies
as well as in transitional countries. Even if the
purpose appears to be different temporarily, it
remains valid as an aim to strive for. In situa-
tions of transition or transitional crisis, however,
it may become necessary to let a modiﬁed pur-
pose prevail, for example if an independent advi-
sory body is needed for conﬂict resolution or to
monitor the adherence within a healthcare institu-
tion to basic principles of ethics. In such a case, a
stricter form of regulation may temporarily be
necessary.
Second, HECs were assigned a supervisory
rather than a reﬂective function mostly early in
the process of political reform in transitional
countries. When in such a situation, HECs are
being implemented into still predominantly
authoritarian structures, stricter regulation may
be justiﬁed because otherwise, setting up a HEC
may prove impossible at all. If this is the case,
regulation should be transformed at a later
stadium of development. Perpetuating strict regu-
lation in a situation where it is not necessary, may
limit the space for reﬂection as well as the
accountability and relevance of HECs in the long
run.
Hence, the arguments in favour of central and
weak regulation may temporarily take on a
different weight. There are circumstances when
regulation needs to be adjusted. However, this
does not change the general preference for central
and weak regulation. Therefore, changes in the
direction of stricter regulation should be rendered
reversible.
Do the arguments shift in view of the European
uniﬁcation?
Finally, the question rises if there are speciﬁc ways
of regulation of HECs, which are desirable in view
of the goals and the process of European uniﬁca-
tion. In general, two types of regulation of ethical
questions in Europe have been established so far.
First, several bioethicists and bioethics organisa-
tions have aimed to determine a substantial ‘Euro-
pean morality. For example, in the EC Convention
on Human Rights and Biomedicine (Council of
Europe, 1997), basic principles were agreed upon
to guide decision-making concerning controversial
moral issues of recent medical technologies.
Another example is the Barcelona Declaration,a
consensus document promoting a set of ideas,
which can form the basis for a diﬀerent set of
moral principles, presumed to be speciﬁcally Euro-
pean (The Barcelona Declaration, 1998; Rendtorﬀ
and Kemp, 2000a, b).
Similar to Beauchamp and Childress (2001),
who have summarised a set of principles of
biomedical ethics including respect for autonomy,
non-maleﬁcence, beneﬁcence and justice, the
Barcelona Declaration deﬁnes four ideas: auton-
omy, dignity, integrity and vulnerability. These
ideas were agreed upon because, ﬁrst, they are
supposed to ﬁt better the situation of people in
need. Second, other than Beauchamps and Chil-
dress principles with roots in the US-American
language of rights and the tradition of utilitarian-
ism, the ideas in the Barcelona Declaration are
thought to better connect to the European tradi-
tions of charity and solidarity in healthcare.
Primarily this applies to the concept of autonomy,
which in the Barcelona Declaration is a collective
term with a number of diﬀerent meanings, and to
the idea of vulnerability, which is based upon the
philosophy of the ‘other by Emanuel Levinas
(1981).
A second type of European bioethics regulation
is procedural. Following the Declaration of Hel-
sinki and other international guidelines, numerous
procedures have been implemented to protect
human subjects in medical research. For example,
the EU Clinical Trials Directive 2001/20/EC makes
prescriptions as to the design of medical research
involving human research subjects (European
Parliament, 2001). Next to presenting the respective
norms, the document prescribes steps on how to
implement these norms in the EU member states.
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already been elaborated, whereas clinical ethics is
lagging behind in this. Copying the regulatory
structure of RECs, however, seems neither desir-
able nor feasible for HECs because of a major
difference between healthcare and medical research
(Miller and Brody, 2003). In regular healthcare
delivery, all decisions and actions are required to
be directed towards the patients good, while
respecting his or her autonomy. In medical
research, however, the beneﬁt of research subjects
is one aspect of a diﬀerent range of valuable aims
to consider. For example, there is a consensus that
insigniﬁcant risks for participants of research are
considered acceptable for the sake of scientiﬁc
progress. Hence, in contrast to clinical ethics, the
ﬁeld of research ethics is structurally determined by
a speciﬁc tension of interest. Therefore, a stricter
form of regulation might be advisable for RECs,
whereas it could be counterproductive for HECs.
The latitude, which appears to be a pre-requisite of
HECs accountability, would fall short of the
stricter requirements for the review of research.
A further speciﬁcity of HECs is that appropri-
ate latitude in regulation can be derived from the
substantial ideas about the ethics of patient care as
phrased in the Barcelona declaration. Therefore,
regulation of HECs cannot only be procedural.
Rather, the ﬁrst mentioned, substantial way of
regulating bioethics forms an essential source for
the regulation as well. Up until now, this source
has not yet been utilised sufﬁciently. Whereas it has
been said that facilitating reﬂection is a main
purpose of HECs, a second purpose can now be
added, namely the advocacy for patients in the
situation of vulnerability. If vulnerability is to be
considered a basic moral principle, which expresses
the obligations of healthcare providers to patients
in a way speciﬁc to European thinking, it could
become a reference point for the regulation of
HECs.
Conclusion
Contributions about the situation in eight Euro-
pean countries have shown that regulation of
HECs is generally less developed than regulation
of RECs. In Eastern Europe, regulation of HECs is
mostly centrally organised and rather strict. In
Western Europe, regulatory structures are weaker
when compared both to Eastern European coun-
tries and to the international regulation of RECs.
Whereas in Belgium and France, there is some
regulation on the national level, the United King-
dom and The Netherlands have opted for non-
regulatory forms of co-operation between HECs.
Assuming that the facilitation of ethical reﬂection
and the development of biomedical citizenship are
general purposes of HECs (Lebeer and Moulin,
2000, 2001; Lebeer, 2003), it has been argued that
centralandweakregulationisthemostappropriate.
Aims of central and cautious regulation would
be to facilitate the committees relevance, their
accountability, and structured ethical deliberation.
As HECs are not disciplinary panels, a societal and
political climate afﬁrmative to ethical reﬂection is
essential. Under conditions adversarial to ethical
reﬂection, a stricter form of regulation may tem-
porarily become justiﬁed. Careful implementation
of central and weak forms of regulation, however,
will remain the main aim, especially within the
process of European uniﬁcation. A temporary
tightening of regulation, which may at times be a
means of choice, should therefore be revoked as
soon as space for ethical reﬂection becomes avail-
able again.
Notes
1. In the USA these committees are also referred to as
institutional review boards (IRBs).
2. In the UK, HECs have been referred to as clinical eth-
ics committees (CECs).
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